AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

168.300

-2.900-1.69%

Volume:2.69M

Turnover:422.09M

Market Cap:80.60B

PE:-22.55

High:171.535

Open:170.000

Low:166.280

Close:171.200

52wk High:219.589

52wk Low:90.000

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.02

T/O Rate:0.56%

Dividend:4.07

Dividend Rate:2.42%

EPS(TTM):-7.465

EPS(LYR):-7.465

ROE:-15.83%

ROA:7.26%

PB:3.90

PE(LYR):-22.55

Loading ...

Overview Company News Filings

CSL (ASX:CSL) Is Up 24.5% After Posting a Net Loss but Guiding for NPAT Growth - What's Changed

Simply Wall St.

Carlisle Companies (CSL) Dividend Hike Puts Its Undervalued Narrative In Focus

Simply Wall St.

Weekly earnings wrap: BHP, CSL, NAB and more

Morning Star AU

ASX healthcare giant rallies despite a fall in profits

Morning Star AU

CSL (ASX:CSL) Reported A Net Loss, Is The Rebound Already Priced In?

Simply Wall St.

Banks Drag Australian Shares Lower; WiseTech Slides Nearly 9%

ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Sector Struggles

MT Newswires Live

Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma

MT Newswires Live

Asia Morning Call-Global Markets

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven

Simply Wall St.

Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook

CSL Expects Flat Revenue for Fiscal 2027 With Return to Profit Growth

MT Newswires Live

CSL's Fiscal 2026 Results In Line, Jefferies Says

MT Newswires Live

Australia's CSL Eyes Best Day in 25 Years on Strong FY Outlook

Csl FY Adjusted Net Income USD 3,100 Million

Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results

THOMSON REUTERS

Australia's CSL Surges 18% on Earnings Beat, Upbeat Plasma Business Forecast

CSL Fiscal 2026 Underlying NPATA Earnings Per Share Down, Revenue Up

MT Newswires Live

CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":168.3,"timestamp":1787292720000,"preClose":171.2,"halted":0,"volume":2686531,"delay":0,"changeRate":-0.016939252336448468,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.464769080507883,"marketStatus":"Market Closed","change":-2.9,"latestTime":"08-21 16:12:00 AEST","open":170,"high":171.535,"low":166.28,"amount":422094220,"amplitude":0.030695,"askPrice":168.48,"askSize":108,"bidPrice":168,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-7.464769080507883,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":171.2,"dividendRate":0.024373,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.0181516551769705,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":171.2,"auctionPrice":168.34,"auctionVolume":585682,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600245}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.464769,"volumeRatio":1.0181516551769705,"shares":478911979,"dividePrice":4.074229,"high":171.535,"amplitude":0.030695,"preClose":171.2,"low":166.28,"week52Low":90,"pbRate":"3.90","psRate":"3.66","week52High":219.589,"institutionHeld":0,"latestPrice":168.3,"committee":-0.911504,"eps":-7.464769080507883,"divideRate":0.024208,"volume":2686531,"delay":0,"ttmEps":-7.464769080507883,"open":170,"prevYearClose":170.408,"prevWeekClose":136.5,"prevMonthClose":123.06,"prevQuarterClose":114.74,"fiveDayClose":136.5,"twentyDayClose":114.22,"sixtyDayClose":97.59,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.018567360626050477},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661925792","title":"CSL (ASX:CSL) Is Up 24.5% After Posting a Net Loss but Guiding for NPAT Growth - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2661925792","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661925792?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:28","pubTimestamp":1787279328,"startTime":"0","endTime":"0","summary":"In August 2026, CSL Limited reported full-year results showing revenue rising slightly to US$15.80 billion but moving from prior net income to a US$2.58 billion net loss, while also declaring a US$1.62 per share dividend for the six months ended June 30, 2026, payable on October 2, 2026.\nAt the same time, CSL issued 2027 guidance calling for revenue to remain in line with the prior year but underlying NPAT to increase by about 5%, highlighting a contrast between current headline losses and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-is-up-245-after-posting-a-net-loss-but-guiding-fo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-is-up-245-after-posting-a-net-loss-but-guiding-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","LU0728928796.USD","LU1169590202.USD","CHAT","BK7511","QTOC","BK7501","SGXZ23171101.USD","LU1169589451.USD","AGIX","ARTY","SG9999004303.SGD","BK4086","CSL.AU","AIPO","BK7508","CSL","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660155477","title":"Carlisle Companies (CSL) Dividend Hike Puts Its Undervalued Narrative In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2660155477","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660155477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:38","pubTimestamp":1787189919,"startTime":"0","endTime":"0","summary":"Dividend increase draws attention to Carlisle Companies stock\nCarlisle Companies (CSL) has drawn investor focus after its board approved a 14% increase in the regular quarterly dividend to $1.25 per share, payable on September 1, 2026.\nSee our latest analysis for Carlisle Companies.\nCarlisle Companies’ dividend move comes after a period where the share price has shown positive momentum in recent months, with an 11.7% 1 month share price return and a 10.0% 3 month share price return, while the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-dividend-hike-puts-its-undervalued-na","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-dividend-hike-puts-its-undervalued-na","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","SGXZ23171101.USD","CSL","SG9999004303.SGD","LU1169590202.USD","BK7067","LU0728928796.USD","BK7511","CSL.AU","LU1169589451.USD","BK7508","BK4086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661254530","title":"Weekly earnings wrap: BHP, CSL, NAB and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2661254530","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661254530?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:00","pubTimestamp":1787155200,"startTime":"0","endTime":"0","summary":"This is the third edition of our weekly wrap for the August 2026 earnings season. Earnings is now in full swing with some of the largest names on the ASX reporting this week. BHP reported strongly on ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/weekly-earnings-wrap-bhp-csl-nab-more","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/weekly-earnings-wrap-bhp-csl-nab-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["VOTE","PMDE","RGLO","FEBU","JOYT","GXDW","CSL","BHP","DECU","VGFPF","BHP.AU","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660470729","title":"ASX healthcare giant rallies despite a fall in profits","url":"https://stock-news.laohu8.com/highlight/detail?id=2660470729","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660470729?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:00","pubTimestamp":1787155200,"startTime":"0","endTime":"0","summary":"CSL’s (ASX.CSL) fiscal 2026 underlying earnings fell 2%, in line with the guidance reset in May, and USD 7.1 billion of impairments drove a statutory loss. Fiscal 2027 guidance is for flat revenue and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-healthcare-giant-rallies-despite-fall-profits","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-healthcare-giant-rallies-despite-fall-profits","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["IXJ","BK7508","VHT","NOBL","BK7067","BK7511","CGCV","CSL.AU","BK4588","BK4585","TCAF","BK7501","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426238","title":"CSL (ASX:CSL) Reported A Net Loss, Is The Rebound Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426238","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426238?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:32","pubTimestamp":1787146321,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is in focus after its latest full year results showed sales and revenue near prior levels, a swing to a net loss, fresh 2027 earnings guidance, and a declared dividend.\nSee our latest analysis for CSL.\nThe earnings announcement, new 2027 guidance and dividend decision have triggered a sharp reassessment of CSL, with a 1-day share price return of 17.25% and a 90-day share price return of 60.27%, even though the 1-year total shareholder return is down 28.29% and the 5-year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-reported-a-net-loss-is-the-rebound-already-priced","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-reported-a-net-loss-is-the-rebound-already-priced","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","BK7067","SGXZ23171101.USD","BK7508","BK4086","BK7501","CSL","BK7511","LU1169590202.USD","LU0728928796.USD","CSL.AU","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660410952","title":"Banks Drag Australian Shares Lower; WiseTech Slides Nearly 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660410952","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660410952?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:02","pubTimestamp":1787122979,"startTime":"0","endTime":"0","summary":"Banks drag Australian shares lower; WiseTech slides nearly 9%Aug 19 (Reuters)-Australian shares ended lower on Wednesday as index heavyweight banks extended falls on concerns over mortgage demand, whi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G0E0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7135","CBA.AU","CSL.AU","ANZ.AU","BK7501","BK7507","BK7511","STO.AU","BK7142","AN3PL.AU","WTC.AU","BK7067","BK7016","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419637","title":"ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419637","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660419637?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:52","pubTimestamp":1787107958,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced nearly 2% at midday Wednesday.CSL (ASX:CSL) gained almost 4% in recent trade.On the flip side, the information technology sector struggled, shedding almost 5%.Wisetech Global (ASX:WTC) shares fell nearly 13% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["III","BK7067","BK7511","XBI","BK4134","BK4581","BK4137","BK7016","XLV","LU0128526141.USD","BK7508","WTC.AU","BK4585","LU0029874061.USD","BK4588","BK7501","CSL.AU","HCSG","BK7503","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660149195","title":"Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660149195","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660149195?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:40","pubTimestamp":1787078411,"startTime":"0","endTime":"0","summary":"Haemonetics  shares were up more than 17% in afternoon trading on Tuesday after the company said it entered into a supply agreement with CSL Plasma last week.The deal involves Haemonetics' NexSys PCS plasma collection system with Persona Plus Technology, an automated cell separator system, along with related disposables in the US, according to a Tuesday filing.CSL is expected to transition a portion of its US plasma collection centers to Haemonetics' devices and disposables, but the scope and timing of the implementation are still to be determined, the company said.Price: 105.99, Change: +15.72, Percent Change: +17.41","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","IE00B64QTZ34.USD","BK4086","CSL.AU","LU0728928796.USD","LU0106261612.USD","LU0012050646.USD","LU1169590202.USD","LU0205194284.USD","SG9999004303.SGD","SGXZ23171101.USD","IE00BLDYK493.USD","BK7508","BK7067","BK4198","IE0034390439.USD","CSL","HAE","IE00B19Z6F94.USD","LU1169589451.USD","BK7511","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660916144","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2660916144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660916144?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:39","pubTimestamp":1787078393,"startTime":"0","endTime":"0","summary":"Asia Morning Call-Global MarketsAug 19 (Reuters)-Stock MarketsNet ChngStock MarketsNet ChngS&P/ASX 200**9070.00-3.20NZX 50**13866.18144.20DJIA53377.48-82.30NIKKEI**67460.73-1,759.52Nasdaq26316.48-327.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU1267930730.SGD","LU2210149790.SGD","LU2210150020.SGD","CSL.AU","LU0289739343.SGD","LU0390134368.USD","FDIQ","LU0511384066.AUD","LU1804176565.USD","LU2265009873.SGD","LU0289961442.SGD","MSCI","LU1691799644.USD","LU0109391861.USD","BK7511","BK4585","BK4588","BK7501","LU0320765059.SGD","LU0672654240.SGD","LU2095319765.USD","LU0175139822.USD","LU0708995401.HKD","BK7067","LU0289960550.SGD","BK7508","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466734","title":"Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466734?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:06","pubTimestamp":1787047565,"startTime":"0","endTime":"0","summary":"Haemonetics signs non-exclusive US plasma supply deal with CSL Plasma for NexSys PCS devices, disposablesHaemonetics signed a non-exclusive U.S. supply agreement with CSL Plasma on Aug. 14, 2026 for N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLpVv5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","IE00B19Z6F94.USD","IE00B64QTZ34.USD","HAE","LU0205194284.USD","IE00BLDYK493.USD","LU1169590202.USD","IE0034390439.USD","BK7067","LU0106261612.USD","BK7511","CSL.AU","LU1169589451.USD","BK4198","LU0012050646.USD","BK7508","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466219","title":"CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466219?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:22","pubTimestamp":1787044958,"startTime":"0","endTime":"0","summary":"CSL stock went into this result having climbed over the past quarter, closing at A$157.82, yet the latest numbers land with a jolt. The global biotech giant posted a trailing twelve month loss from continuing operations of US$2.99b on revenue of US$15.80b. That kind of earnings squeeze grabs short term traders by the throat. For long term investors, the real question now is how to weigh that loss against analyst forecasts that point to a return to profitability, as well as the current gap...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PMDE","LU0728928796.USD","DECU","BK7067","FEBU","JOYT","GXDW","BK4086","CSL.AU","CSL","SG9999004303.SGD","RGLO","LU1169589451.USD","SGXZ23171101.USD","BK7511","VOTE","BK7501","BK7508","LU1169590202.USD","VGFPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454593","title":"Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454593","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454593?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:26","pubTimestamp":1787030795,"startTime":"0","endTime":"0","summary":"Switzerland's Basilea H1 revenue rises on Cresemba demand; ups 2026 profit outlookOverviewSwitzerland biopharma firm's H1 2026 revenue grew 14% yr/yr to CHF 119 mlnOperating profit for H1 2026 rose 32","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979443071.USD","HK0000306685.HKD","BK1230","BK0239","02696","LU1064131003.USD","002422","LU0196878994.USD","BK7067","00656","BK7501","BK0060","LU2148510915.USD","BK7508","CSL.AU","HK0000320264.USD","BK1161","HK0000165453.HKD","HK0000306701.USD","BK7511","06990","HK0000320223.HKD","LU1934453819.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660645155","title":"CSL Expects Flat Revenue for Fiscal 2027 With Return to Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2660645155","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660645155?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:24","pubTimestamp":1787027041,"startTime":"0","endTime":"0","summary":"CSL  expects fiscal 2027 revenue to be flat while making a return to profit growth after fiscal 2026 results beat estimates amid restructuring.The biotechnology company reported $6.43 in underlying NPATA earnings per share for fiscal 2026, compared with $6.65 a year ago and beating analysts' estimates surveyed by FactSet of $6.27.Revenue for the year was $15.8 billion, beating the estimate of $15.38 billion from analysts polled by FactSet, while paying restructuring costs of $799 million.The biotechnology firm attributed the results to \"strong fundamentals\" of the plasma industry and said momentum is building behind its newer therapy products.Looking ahead, CSL expects fiscal 2027 revenue to be flat with 5% growth in its underlying net profit after tax.\"CSL is positioned for a return to sustainable growth, supported by solid plasma market fundamentals, a simplified business and targeted investment in our commercial capabilities and development programs,\" said Interim Chief Executive Of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","CSL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660745574","title":"CSL's Fiscal 2026 Results In Line, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660745574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660745574?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:00","pubTimestamp":1787018443,"startTime":"0","endTime":"0","summary":"CSL's  fiscal 2026 results are in line, and it guided for fiscal 2027 net profit after tax  growth of around 5%, Jefferies said in a Tuesday note.The firm's normalized fiscal 2026 net profit after tax and before amortization of $3.1 billion fell around 4% year-over-year and 2% in constant currency, compared with the brokerage's forecast of $3.09 billion.Its fiscal 2026 normalized earnings per share of $5.38 decreased around 3% on the year-ago period, compared with Jefferies' estimate of $5.76.Its fiscal 2027 revenue is expected by the firm to be in line with the prior year and underlying NPAT growth of around 5%, implying an underlying CSL fiscal 2027 NPAT of around $2.98 billion on a constant currency basis, compared with Jefferies' forecast of $2.8 billion on a non-constant currency basis.The investment firm assigned CSL a hold rating and a price target of AU$119 per share.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0728928796.USD","BK7511","BK4086","LU1169589451.USD","SG9999004303.SGD","SGXZ23171101.USD","BK7501","CSL.AU","BK7067","CSL","BK7508","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453002","title":"Australia's CSL Eyes Best Day in 25 Years on Strong FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453002","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453002?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:20","pubTimestamp":1787016055,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL eyes best day in 25 years on strong FY outlook** Shares of CSLCSL.AXrise as much as 18.1% to A$159.01, hitting their highest level since February 12** Stock set for best intraday trading session since June 2001** Biotech giant reportsbetter-than-expectedfull-year underlying earnings and forecasts strong growth in 2027 on the back of its core plasma division** CSL posts underlying NPAT attributable of $3.14 bln on a constant currency basis, topping Visible Alpha consensus estimate of $3.08 bln** Plasma therapies unit CSL Behring expected to post mid-single-digit revenue growth in FY 2027** Co unveils A$1.1 bln  share buyback programme** With much of the earnings damage already reflected in a share price near multi-year lows, the buyback and a more constructive outlook for Behring are strengthening view that the worst may be behind CSL - Hebe Chen, market analyst at Vantage Markets** Day's moves cut stock's YTD losses to 9.2%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F01G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","BK4585","IAI","LU1989772923.USD","BK4597","LU0154236417.USD","LU1804176565.USD","LU2265009873.SGD","LU0868494617.USD","BK4581","LU2089283258.USD","LU2095319765.USD","BK4548","LU2506952097.USD","LU0158827781.USD","LU0158827948.USD","LU0097036916.USD","CSL.AU","LU0354030438.USD","LU1363072403.SGD","SGXZ31699556.SGD","LU1633808545.USD","SPGI","LU2271345857.HKD","FDIQ","LU2210150020.SGD","LU1989764664.SGD","LU1496350502.SGD","BK7067","BK4566","BK4534","LU2764263039.SGD","BK7501","SG9999017495.SGD","BK4112","LU2089284900.SGD","LU2506952170.USD","LU0342679015.USD","SG9999001077.SGD","LU2720916845.USD","LU1988902786.USD","LU0094547139.USD","LU1989773731.SGD","LU2506951875.HKD","IE00B19Z9505.USD","SG9999014880.SGD","LU1989763005.USD","SG9999014898.SGD","LU0175139822.USD","LU0823417737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453908","title":"Csl FY Adjusted Net Income USD 3,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453908","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453908?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:02","pubTimestamp":1787014965,"startTime":"0","endTime":"0","summary":"BRIEF-Csl FY Adjusted Net Income USD 3,100 MillionAug 18 -CSL LimitedCSL.AX:FY ADJUSTED NET INCOME USD 3,100 MILLIONSEES FY UNDERLYING NPAT GROWTH OF  APPROXIMATELY 5%DIVIDEND MAINTAINED; SHARE BUY-BACK  PROGRAM CONTINUEDCSL SEQIRUS EXPECTS LOW SINGLE DIGIT REVENUE GROWTH IN FYSEES FY27 REVENUE TO BE IN LINE WITH THE PRIOR YEAR AND UNDERLYING NPAT GROWTH OF APPROXIMATELY 5%CSL BEHRING EXPECTS MID-SINGLE DIGIT REVENUE GROWTH IN FYANNOUNCE A FURTHER  A$1.1 BILLION SHARE BUY-BACK PROGRAMRECOGNISED PRE-TAX IMPAIRMENTS OF $5.5 BILLION IN 2H FY26INTENTION TO SPEND APPROXIMATELY $1.5 BILLION TO EXPAND ITS U.S. PLASMA  MANUFACTURING PRESENCEFurther company coverage:CSL.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nPLXMQ2BQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660458382","title":"Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660458382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660458382?lang=en_us&edition=fundamental","pubTime":"2026-08-18 08:02","pubTimestamp":1787011343,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7511","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660305504","title":"Australia's CSL Surges 18% on Earnings Beat, Upbeat Plasma Business Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2660305504","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660305504?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:54","pubTimestamp":1787007265,"startTime":"0","endTime":"0","summary":"UPDATE 2-Australia's CSL surges 18% on earnings beat, upbeat plasma business forecastAug 18 (Reuters)-CSLCSL.AXreported better-than-expected annual underlying earnings on Tuesday and forecast growth i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E1FT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014898.SGD","LU2095319765.USD","SG9999017495.SGD","IE00B19Z9505.USD","LU0345774631.USD","LU1989773731.SGD","SG9999018857.SGD","SPGI","BK4581","IAI","LU2023251221.USD","LU2210150020.SGD","LU1496350171.SGD","SGXZ31699556.SGD","SG9999014914.USD","BK7501","SG9999001077.SGD","LU0289960550.SGD","LU2264538146.SGD","LU2506952170.USD","LU2720916845.USD","LU2764263203.CNY","LU1496350502.SGD","LU0175139822.USD","LU1989764664.SGD","LU1064131342.USD","BK4112","LU0823417737.USD","LU2506951875.HKD","LU0971096721.USD","LU0823417653.USD","LU1804176565.USD","LU2265009873.SGD","FDIQ","LU2506952097.USD","LU0985320562.USD","LU0868494617.USD","LU2089284900.SGD","LU0094547139.USD","SG9999014880.SGD","LU0345774391.USD","BK4566","LU0097036916.USD","LU2089283258.USD","LU0950375773.USD","LU2506951958.HKD","LU2271345857.HKD","CSL.AU","BK4585","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660038437","title":"CSL Fiscal 2026 Underlying NPATA Earnings Per Share Down, Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660038437","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660038437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:27","pubTimestamp":1787005653,"startTime":"0","endTime":"0","summary":"CSL  logged $6.43 in underlying NPATA earnings per share for fiscal 2026, compared with $6.65 a year ago, a Tuesday filing showed.Analysts polled by FactSet expected $6.27.For the 12 months ended June 30, revenue was $15.8 billion versus $15.56 billion previously, the Australia-listed biotechnology company added. Analysts surveyed by FactSet expected $15.38 billion.The company's board declared a final dividend of $1.62 per share, unchanged from a year earlier, payable Oct. 2 to shareholders of record as of Sept. 10.CSL said it expects fiscal 2027 revenue to be in line with fiscal 2026, and underlying net profit after tax growth of about 5%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437278","title":"CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437278","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437278?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:14","pubTimestamp":1787004898,"startTime":"0","endTime":"0","summary":"CSL FY26 underlying NPATA falls 2% to US$3.1 billion; reported net loss widens to US$2.6 billionCSL posted a net loss after tax of US$2.6 billion, swinging from profit, on one-off restructuring costs,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2bJkFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}